OHSU Innovates

OHSU has a strong track record of innovation in oncology, and this year's Impact Report highlights two projects working to improve cancer prevention and detection. Read about work to develop a cancer vaccine by Klaus Frueh and colleagues, and a tool for the detection of metastatic cancer by Yu-Jui Chiu, Melissa Wong, and Jose Montoya Mira, MS, PhD (pictured below). Read the full report here: https://lnkd.in/gv7zDg8w

The OHSU Innovates team gathered last night to support innovative new bioscience companies at the AOBIO investment mixer. Congratulations to all the finalists, including OHSU startup NeuraMedica Inc., and to Axia Orthopedics, the night's angel investment winner. It was also fantastic to hear from OHSU's Aditi Martin, receive updates on last year’s winner ProMedix Inc - Precision Medical Devices, and reconnect with OHSU entrepreneurs. A big thank you to the Oregon Entrepreneurs Network for organizing a great event!

Check out the OHSU Innovates 2024 Impact Report to learn more about innovations revolutionizing eyecare happening at the OHSU Casey Eye Institute. The report features highlights recent national recognition for researcher David Huang, and the work of J. Peter Campbell and Yifan Jian with the OHSU startup Siloam Vision.

It's that time of year where we are excited to share our annual impact report! Delve into inspiring stories about new healthcare innovations, startups and collaborations happening at OHSU. This year's report highlights four focus areas where OHSU innovators are making a difference: ophthalmology, infectious disease, behavioral health and oncology. Visit our webpage to download the report and get inspired! https://lnkd.in/gm8HuqZ7

Get your tickets now for the Angel Oregon Life and Bioscience Investment mixer! Hosted by the Oregon Entrepreneurs Network this evening will celebrate innovations in the life and bioscience industry. AOBIO investors will also announce which of the finalists will receive the more than $100,000 investment.?Good luck to all the finalists, including OHSU startup company NeuraMedica Inc. and CEO Rachel Dreilinger!

If you missed our last seminar on "Advancing Care: Non-profits driving rare disease research" you can catch the recording on YouTube. This powerful session featured discussion about the challenges and strategies for funding rare disease research and innovations. Thank you again to our excellent speakers, Penny Hogarth, M.D., and Tommy Pham ??, for sharing their insights.

We are thrilled to have an OHSU startup company win at Bend Venture Conference (BVC)! Congratulations to ProMedix Inc - Precision Patient Monitoring on taking home the growth stage finalist prize and a $200k investment! Shoutout to CEO Scott Filer and OHSU co-founders David Sheridan MD MCR and Matt Hansen! ProMedix is developing a noninvasive medical device that accelerates diagnosis of circulatory dysfunction and sepsis.

Don't forget to register for the next OHSU Innovates seminar "Advancing Care: Non-Profits Driving Rare Disease Innovation." This seminar is free and open to all! Register at: https://lnkd.in/gVzwa33s

Congratulations to the winners of the Biotech Summit and Innovation Showcase, including OHSU presenters Matthew Rames and J. Peter Campbell! The OHSU startup Verendus Pharma, based on research from the laboratory of Michael Cohen, also took home the early-stage company judge's choice award! Thank you to the Oregon Bioscience Association for putting on a great event highlighting some of the ground-breaking bioscience research happening in the state. Read more about the OHSU winners here: https://lnkd.in/gPcAqpSM

Congrats to OHSU startup ProMedix Inc - Precision Medical Devices on being named one of the four growth stage finalists that will take the stage at Bend Venture Conference (BVC)! ProMedix is developing a noninvasive medical device that accelerates diagnosis of circulatory dysfunction and sepsis.